TGFβ induces the formation of tumour-initiating cells in claudin low breast cancer

Nature Communications

Volumn 3, Issue , 2012, Pages

  Bruna, Alejandra ^a,b   Greenwood, Wendy ^a,b   Le Quesne, John ^a,b   Teschendorff, Andrew ^c   Miranda Saavedra, Diego ^d   Rueda, Oscar M ^a,b   Sandoval, Jose L ^a,b   Vidakovic, Ana Tufegdzic ^a,b   Saadi, Amel ^a,b   Pharoah, Paul ^b,e,f   Stingl, John ^a,b   Caldas, Carlos ^a,b,f  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f Cambridge Experimental Cancer Medicine Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA6 INTEGRIN; CD24 ANTIGEN; CLAUDIN; HERMES ANTIGEN; PROTEIN NEDD9; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SCAFFOLD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL CELL; BREAST CANCER; BREAST EPITHELIUM; BREAST TUMOR INITIATING CELL; CANCER CELL CULTURE; CELL COMPARTMENTALIZATION; CELL COUNT; CELL RENEWAL; CELL SUBPOPULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; POSITIVE FEEDBACK; SIGNAL TRANSDUCTION; STEM CELL; TUMOR CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BREAST NEOPLASMS; CHROMATIN IMMUNOPRECIPITATION; CLAUDINS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MICE; NEOPLASTIC STEM CELLS; PHOSPHOPROTEINS; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84867027347     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2039     Document Type: Article

References (59)

1. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003). (Pubitemid 36418143)
2. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J. & Maitland, N. J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951 (2005). (Pubitemid 41713363)
3. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115 (2007). (Pubitemid 46067311)
4. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007). (Pubitemid 46067310)
5. Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 (2007). (Pubitemid 350056407)
6. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
7. Sørlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869-10874 (2001). (Pubitemid 32878711)
8. Hennessy, B. T. et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 69, 4116-4124 (2009).
9. Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68 (2010).
10. Proia, T. A. et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 8, 149-163 (2011).
11. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15, 907-913 (2009).
12. Stingl, J. & Caldas, C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat. Rev. Cancer 7, 791-799 (2007). (Pubitemid 47463670)
13. Massagué, J. TGFbeta in Cancer. Cell 134, 215-230 (2008).
14. Bierie, B. & Moses, H. L. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6, 506-520 (2006). (Pubitemid 43980540)
15. Dumont, N. & Arteaga, C. L. Targeting the TGF beta signaling network in human neoplasia. Cancer Cell 3, 531-536 (2003). (Pubitemid 36808648)
16. Bierie, B. & Moses, H. L. Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis. Cell Cycle 8, 3319-3327 (2009).
17. Padua, D. et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66-77 (2008). (Pubitemid 351442989)
18. Bierie, B. et al. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. J. Clin. Invest. 119, 1571-1582 (2009).
19. Nishimura, E. K. et al. Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell 6, 130-140 (2010).
20. Ikushima, H. et al. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5, 504-514 (2009).
21. Scheel, C. et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell States in the breast. Cell 145, 926-940 (2011).
22. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008). (Pubitemid 351636299)
23. Shipitsin, M. et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259-273 (2007). (Pubitemid 46349843)
24. Tang, B. et al. Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res. 67, 8643-8652 (2007). (Pubitemid 47437440)
25. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003). (Pubitemid 36583168)
26. Stingl, J., Eaves, C. J., Zandieh, I. & Emerman, J. T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat 67, 93-109 (2001). (Pubitemid 32744490)
27. Xu, Y. D. et al. Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L527-539 (2003). (Pubitemid 37022852)
28. Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J. & Massagué, J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl Acad. Sci. USA 100, 8430-8435 (2003). (Pubitemid 36842562)
29. Stingl, J., Eaves, C. J., Zandieh, I. & Emerman, J. T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 67, 93-109 (2001). (Pubitemid 32744490)
30. Eirew, P. et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat. Med. 14, 1384-1389 (2008).
31. Eirew, P., Stingl, J. & Eaves, C. J. Quantitation of human mammary epithelial stem cells with in vivo regenerative properties using a subrenal capsule xenotransplantation assay. Nat. Protoc. 5, 1945-1956 (2010).
32. Stingl, J. et al. Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997 (2006). (Pubitemid 43292419)
33. Kalkhoven, E. et al. Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ. 6, 1151-1161 (1995).
34. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005). (Pubitemid 41528093)
35. Müller, F.-J. et al. Regulatory networks define phenotypic classes of human stem cell lines. Nature 455, 401-405 (2008).
36. Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-352 (2012).
37. Pece, S. et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62-73 (2010).
38. Bussemaker, H. J., Li, H. & Siggia, E. D. Regulatory element detection using correlation with expression. Nat. Genet. 27, 167-171 (2001). (Pubitemid 32157443)
39. Gao, F., Foat, B. C. & Bussemaker, H. J. Defining transcriptional networks through integrative modeling of mRNA expression and transcription factor binding data. BMC Bioinformatics 5, 31 (2004).
40. Medjkane, S., Perez-Sanchez, C., Gaggioli, C., Sahai, E. & Treisman, R. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat. Cell Biol. 11, 257-268 (2009).
41. Muraoka, R. S. et al. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1. Mol. Cell Biol. 23, 8691-8703 (2003). (Pubitemid 37433371)
42. Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J. & Massague, J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl Acad. Sci. USA 100, 8430-8435 (2003). (Pubitemid 36842562)
43. Forrester, E. et al. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 65, 2296-2302 (2005). (Pubitemid 40490139)
44. Padua, D. et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66-77 (2008). (Pubitemid 351442989)
45. Bierie, B. et al. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res. 68, 1809-1819 (2008). (Pubitemid 351416566)
46. Prat, A. & Perou, C. M. Mammary development meets cancer genomics. Nat. Med. 15, 842-844 (2009).
47. Oft, M. et al. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10, 2462-2477 (1996). (Pubitemid 26341881)
48. Taube, J. H. et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl Acad. Sci. USA 107, 15449-15454 (2010).
49. Posern, G. & Treisman, R. Actin′ together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 16, 588-596 (2006). (Pubitemid 44636222)
50. Morita, T., Mayanagi, T. & Sobue, K. Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs). Exp. Cell Res. 313, 3432-3445 (2007). (Pubitemid 47407747)
51. Vogel, T., Ahrens, S., Büttner, N. & Krieglstein, K. Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component. Cereb. Cortex 20, 661-671 (2010).
52. Zheng, M. & McKeown-Longo, P. J. Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion. J. Biol. Chem. 277, 39599-39608 (2002). (Pubitemid 35190940)
53. Giampieri, S. et al. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 11, 1287-1296 (2009).
54. Sanz-Moreno, V. et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135, 510-523 (2008).
55. Schmidt, D. et al. ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods 48, 240-248 (2009).
56. Eirew, P. et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat. Med. 14, 1384-1389 (2008).
57. Neve, R. M. et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527 (2006). (Pubitemid 44854747)
58. Dunning, M. J., Smith, M. L., Ritchie, M. E. & Tavare, S. beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 23, 2183-2184 (2007). (Pubitemid 47394121)
59. Barbosa-Morais, N. L. et al. A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data. Nucleic Acids Res. 38, e17 (2010).